Incretin combination therapy for the treatment of non-alcoholic steatohepatitis
Diabetes, Obesity and Metabolism 22(8):1328-1338, 2020
Glucagon resistance at the level of amino acid turnover in obese subjects with hepatic steatosis
Diabetes 69(6):1090-1099, 2020
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
Scientific Reports 10(1):1148, 2020
Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice
Physiology Reports 7(24):e14333, 2019
The dorsomedial hypothalamus and nucleus of the solitary tract as key regulators in a rat model of chronic obesity
Brain Research 1727:146538, 2020
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
World Journal of Gastroenterology 25(33):4904-4920, 2019
Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion
Liver International 39(11):2094-2101, 2019